Annual Total Liabilities
$6.10 M
-$5.69 M-48.27%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual total liabilities is $6.10 million, with the most recent change of -$5.69 million (-48.27%) on December 31, 2023.
- During the last 3 years, NRBO annual total liabilities has risen by +$2.33 million (+61.91%).
- NRBO annual total liabilities is now -64.36% below its all-time high of $17.11 million, reached on December 31, 2018.
Performance
NRBO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$9.19 M
-$616.00 K-6.28%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly total liabilities is $9.19 million, with the most recent change of -$616.00 thousand (-6.28%) on September 30, 2024.
- Over the past year, NRBO quarterly total liabilities has increased by +$3.10 million (+50.80%).
- NRBO quarterly total liabilities is now -59.47% below its all-time high of $22.68 million, reached on June 30, 2016.
Performance
NRBO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NRBO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.3% | +50.8% |
| 3 y3 years | +61.9% | +370.9% |
| 5 y5 years | -64.4% | +199.2% |
NRBO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.3% | +176.8% | -22.0% | +636.0% |
| 5 y | 5-year | -48.3% | +180.2% | -22.0% | +811.1% |
| alltime | all time | -64.4% | +593.5% | -59.5% | +811.1% |
NeuroBo Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.19 M(-6.3%) |
| Jun 2024 | - | $9.81 M(+41.3%) |
| Mar 2024 | - | $6.94 M(+13.9%) |
| Dec 2023 | $6.10 M(-48.3%) | $6.10 M(+25.0%) |
| Sep 2023 | - | $4.88 M(+22.4%) |
| Jun 2023 | - | $3.98 M(-63.7%) |
| Mar 2023 | - | $10.98 M(-6.8%) |
| Dec 2022 | $11.78 M(+435.1%) | $11.78 M(+627.9%) |
| Sep 2022 | - | $1.62 M(+29.6%) |
| Jun 2022 | - | $1.25 M(-18.5%) |
| Mar 2022 | - | $1.53 M(-30.4%) |
| Dec 2021 | $2.20 M(-41.5%) | $2.20 M(+12.8%) |
| Sep 2021 | - | $1.95 M(+57.3%) |
| Jun 2021 | - | $1.24 M(+23.0%) |
| Mar 2021 | - | $1.01 M(-73.2%) |
| Dec 2020 | $3.77 M | $3.77 M(+2.0%) |
| Sep 2020 | - | $3.69 M(+14.9%) |
| Jun 2020 | - | $3.21 M(-15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.79 M(+74.4%) |
| Dec 2019 | $2.18 M(-87.3%) | $2.18 M(-29.2%) |
| Sep 2019 | - | $3.07 M(+49.9%) |
| Jun 2019 | - | $2.05 M(+19.7%) |
| Mar 2019 | - | $1.71 M(-90.0%) |
| Dec 2018 | $17.11 M(+13.5%) | $17.11 M(+22.0%) |
| Sep 2018 | - | $14.02 M(+1.9%) |
| Jun 2018 | - | $13.76 M(-1.9%) |
| Mar 2018 | - | $14.02 M(-7.0%) |
| Dec 2017 | $15.08 M(+265.7%) | $15.08 M(-7.3%) |
| Sep 2017 | - | $16.26 M(+208.3%) |
| Jun 2017 | - | $5.27 M(+16.0%) |
| Mar 2017 | - | $4.54 M(+10.3%) |
| Dec 2016 | $4.12 M(-75.6%) | $4.12 M(+112.9%) |
| Sep 2016 | - | $1.94 M(-91.5%) |
| Jun 2016 | - | $22.68 M(+907.1%) |
| Mar 2016 | - | $2.25 M(-86.7%) |
| Dec 2015 | $16.87 M(+1819.2%) | $16.87 M |
| Dec 2014 | $879.00 K | - |
FAQ
- What is NeuroBo Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual total liabilities year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly total liabilities year-on-year change?
What is NeuroBo Pharmaceuticals annual total liabilities?
The current annual total liabilities of NRBO is $6.10 M
What is the all time high annual total liabilities for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual total liabilities is $17.11 M
What is NeuroBo Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, NRBO annual total liabilities has changed by -$5.69 M (-48.27%)
What is NeuroBo Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of NRBO is $9.19 M
What is the all time high quarterly total liabilities for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly total liabilities is $22.68 M
What is NeuroBo Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, NRBO quarterly total liabilities has changed by +$3.10 M (+50.80%)